Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo

NCT02998541 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

219

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision, unrelated to safety

Conditions

Adenoviral Conjunctivitis

Interventions

DRUG: SHP640
DRUG: PVP-I 0.6%
OTHER: Placebo

Sponsor

Shire